Having of mortality at 1 year by domiciliary thrombolysis in the grampian region early anistreplase trial (GREAT)

Journal of the American College of Cardiology

Volumn 23, Issue 1, 1994, Pages 1-5

  Rawles, John ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANISTREPLASE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; FEMALE; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANISTREPLASE; FEMALE; HOUSE CALLS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SCOTLAND; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0028049159     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(94)90494-4     Document Type: Article

References (24)

1. The wavefront phenomenon of ischaemic cell death. I. Myocardial infarct size vs duration of coronary occlusion in dogs
2. Effects of coronary artery reperfusion on myocardial infarct size and survival in conscious dogs
3. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography
4. Salvage of myocardial function by coronary artery reperfusion 1 2 and 3 hours after occlusion in conscious dogs
5. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
6. Randomised trial of intravenous streptokinase oral aspirin both or neither among 17187 cases of suspected acute myocardial infarction ISIS-2
7. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial
8. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
9. Initial pain course and delay to hospital admission in relation to myocardial infarct size
10. Early versus late hospital arrival for acute myocardial infarction in the Western Washington thrombolytic therapy trials
11. Patient and general practitioner delays in acute myocardial infarction
12. Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarction
13. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-Hospital Study Group and the Cincinnati Heart Project
14. Time delays in provision of thrombolytic treatment in six district hospitals
15. Feasibility safety and efficacy of domiciliary thrombolysis by general practitioners
16. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction
17. Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction
18. Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction
19. Anistreplase in early acute myocardial infarction and the one-year follow-up
20. Effect of treatment delay on myocardial infarct size [letter]
21. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study
22. Prehospital thrombolysis in acute myocardial infarction
23. Prehospital use of APSAC results of a placebo-controlled study